• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.01% Nasdaq Up0.26%

    Insmed Incorporated (INSM)

    16.59 Up 0.55(3.43%) Nov 25, 4:00PM EST
    ProfileGet Profile for:
    Insmed Incorporated
    10 Finderne Avenue
    Building 10
    Bridgewater, NJ 08807
    United States - Map
    Phone: 908-977-9900
    Website: http://www.insmed.com

    Index Membership:N/A
    Full Time Employees:89

    Business Summary 

    Insmed Incorporated, a biopharmaceutical company, focuses on developing and commercializing inhaled therapies for patients with serious lung diseases. Its lead product candidate is ARIKAYCE, an inhaled antibiotic treatment that delivers an anti-infective directly to the site of serious lung infections. The company’s ARIKAYCE is in Phase III clinical trial for patients with lung infections caused by non-tuberculous mycobacteria (NTM) in the United States and Canada; and completed a Phase III clinical trial in Europe and Canada for cystic fibrosis (CF) patients with Pseudomonas aeruginosa lung infections. It also focuses on the development of INS1009, an inhaled treprostinil prodrug for the treatment of pulmonary arterial hypertension. Insmed Incorporated was founded in 1999 and is headquartered in Bridgewater, New Jersey.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Insmed Incorporated

    Corporate Governance 
    Insmed Incorporated’s ISS Governance QuickScore as of Nov 1, 2015 is 8. The pillar scores are Audit: 2; Board: 4; Shareholder Rights: 10; Compensation: 8.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
    Mr. William H. Lewis , 46
    Chief Exec. Officer, Pres and Director
    Mr. Andrew T. Drechsler , 43
    Chief Financial Officer
    Ms. Christine A. Pellizzari , 47
    Gen. Counsel and Corp. Sec.
    Ms. S. Nicole Schaeffer , 47
    Sr. VP of HR & Corp. Services
    Mr. Walter Perkins Ph.D.,
    Chief Technology Officer
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders